Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Todd

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
BMJ Quality & Safety|October 23, 2024
Beyond polypharmacy to the brave new world of minimum datasets and artificial intelligence: thumbing a nose to HenryAdam Todd, Barbara Hanratty
European Journal of Public Health|January 4, 2021
Learning from past mistakes? The COVID-19 vaccine and the inverse equity hypothesisAdam Todd, Clare Bambra
Clinics in Geriatric Medicine|April 3, 2017
The Role of Patient Preferences in DeprescribingHolly M Holmes, Adam Todd
JAMA Internal Medicine|March 24, 2015
Evidence-based deprescribing of statins in patients with advanced illnessHolly M Holmes, Adam Todd
The International Journal of Pharmacy Practice|August 27, 2024
Building on the success of pharmaceutical public health: is it time to focus on health inequalities?Adam Todd, Diane Ashiru-Oredope
International Journal of Clinical Pharmacy|June 17, 2015
Recommendations to support deprescribing medications late in lifeAdam Todd, Holly M Holmes
Advanced Drug Delivery Reviews|August 18, 2018
Challenges and innovations of delivering medicines to older adultsDanijela Gnjidic, Andy Husband, Adam Todd
Perspectives in Public Health|April 15, 2015
Benefits and barriers to the public health pharmacy: a qualitative exploration of providers' and commissioners' perceptions of the Healthy Living Pharmacy frameworkHannah Firth, Adam Todd, Clare Bambra
American Journal of Pharmaceutical Education|April 25, 2014
Integrating science and practice in pharmacy curriculaAndrew K Husband, Adam Todd, John Fulton
Expert Opinion on Pharmacotherapy|October 8, 2021
How should a physician assess medication burden and polypharmacy?Anum Iqbal, Fiona Matthews, Barbara Hanratty, et al.
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
BMJ Quality & Safety|October 23, 2024
Beyond polypharmacy to the brave new world of minimum datasets and artificial intelligence: thumbing a nose to HenryAdam Todd, Barbara Hanratty
European Journal of Public Health|January 4, 2021
Learning from past mistakes? The COVID-19 vaccine and the inverse equity hypothesisAdam Todd, Clare Bambra
Clinics in Geriatric Medicine|April 3, 2017
The Role of Patient Preferences in DeprescribingHolly M Holmes, Adam Todd
JAMA Internal Medicine|March 24, 2015
Evidence-based deprescribing of statins in patients with advanced illnessHolly M Holmes, Adam Todd
The International Journal of Pharmacy Practice|August 27, 2024
Building on the success of pharmaceutical public health: is it time to focus on health inequalities?Adam Todd, Diane Ashiru-Oredope
International Journal of Clinical Pharmacy|June 17, 2015
Recommendations to support deprescribing medications late in lifeAdam Todd, Holly M Holmes
Advanced Drug Delivery Reviews|August 18, 2018
Challenges and innovations of delivering medicines to older adultsDanijela Gnjidic, Andy Husband, Adam Todd
Perspectives in Public Health|April 15, 2015
Benefits and barriers to the public health pharmacy: a qualitative exploration of providers' and commissioners' perceptions of the Healthy Living Pharmacy frameworkHannah Firth, Adam Todd, Clare Bambra
American Journal of Pharmaceutical Education|April 25, 2014
Integrating science and practice in pharmacy curriculaAndrew K Husband, Adam Todd, John Fulton
Expert Opinion on Pharmacotherapy|October 8, 2021
How should a physician assess medication burden and polypharmacy?Anum Iqbal, Fiona Matthews, Barbara Hanratty, et al.
Pageof 13